压力应激动物模型在肿瘤中的应用和研究现状

目的就各类压力应激荷瘤动物模型的造模方法进行综述,对其特点进行评述,并分析了压力应激在肿瘤发生发展中的作用机制。方法应用计算机检索PubMed数据库（2000／2013）,以“stress,animalmodel,tumor”为检索词;检索中国知识资源总库（2000～2013）、重庆维普数据库（2000～2013）、万方数据库（2000～2013）三大中文期刊数据库,以“应激,动物模型,肿瘤”为检索词。文章所述内容需与应激动物模型的建立、应用、评价,及压力应激与肿瘤的关系等方面研究密切相关,排除重复性研究。结果共收集596篇关于应激动物模型的文献,中文156篇,英文440篇。阅读标题和摘要进行初筛,排除发表时间较早、重复及类似的研究,纳入30篇符合标准的文献。结论压力应激与肿瘤研究领域为进一步从抗焦虑、抑郁等角度筛选抗肿瘤药物提供参考。     

NCBI的数据库资源及其应用

NCBI是美国的一个大型生物信息学系统,它主要通过NCBI网站为全世界的科学家服务,它拥有GenBank,RefSeq,UniGene,dbSNP等等多种大型生物学数据库,并且提供了多种数据库查询工具,如：Entrez,PubMed,LocusLink,TaxonomyBrowser等等,以及多种数据库分析资源,对于我们查询文献,人类基因组信息、基因表达、蛋白质结构、肿瘤遗传信息,以及不同种属遗传信息等等有非常大的帮助。是一个非常重要的生物医学资源。     

“农作物害虫数据库”的开发研究

开发研究了把数字技术应用到农业生产以及农业教育中,并结合农业生产实际,建立了“农作物害虫数据库”。该数据库包括鳞翅目、鞘翅目、半翅目、同翅目、双翅目、膜翅目、直翅目、蜱螨目和缨翅目等149种新疆主要农作物害虫,812幅原色图和害虫防治技术信息,用户可通过8种检索途径,采用9种检索方法方便地查询相关信息。     

中国汉族人群66个InDel基因座的遗传多态性

插入/缺失多态性(insertion/deletion polymorphism,InDel)遗传标记是一类由DNA片段的插入或者缺失形成的变异形式,在降解检材身份识别领域展现出优势.本文从dbSNP数据库中自主筛选66个InDel基因座,基于高通量测序系统建立了一套多重复合扩增体系(66-plex InDels).通...     

ASD及其在基因选择性剪接检索中的应用

在生物信息学的飞速发展中,与之相应的各种类型的数据库不断涌现,选择性剪接数据库（Alternative Splicing Database）便是其中之一。本文详细介绍了ASD数据库的主要内容及其功能,并在其子数据库AltSplice中检索NGAL基因的选择性剪接,由此为例说明了ASD数据库在基因选择性剪接检索中的应用。     

基于Ovid平台的BIOSIS Preview数据库检索应用初探

本文详细介绍了Ovid平台的BIOSIS Preview数据库检索途径、方法以及特色,并应用实例进行了检索示范.     

检索表的矛盾分析及其实践意义(综述)

通过对生物检索表结构的分析,认为检索表的根本矛盾是标本具有的个性性状与检索表使用的共性性状的矛盾。单道检索表的主要矛盾是检索表对性状的有条件使用与单个标本性状有限性之间的矛盾,因而单道检索表未能很好地解决其基本矛盾,使得其应用范围和使用效果受到诸多影响。多道检索表的主要矛盾是性状数据库内性状的有限性与物种具有的个性性状的无限性之间的矛盾,不存在个性与共性的矛盾,即解决了根本矛盾问题,便于检索应用。     

蛋白质二级结构预测样本集数据库的设计与实现

将数据库技术应用到蛋白质二级结构预测的样本集处理和分析上,建立了二级结构预测样本集数据库。以CB513样本集为例介绍了该数据库的构建模式。构建样本数据库不仅便于存储、管理和检索数据,还可以完成一些简单的序列分析工作,取代许多以往必须的编程。从而大大提高了工作效率,减少错误的发生。     

蛋白质- 配体相互作用信息数据库研究进展

研究蛋白质和配体相互作用的结构和亲和力,不仅有助于了解蛋白质的功能,而且对药物研发以及药物作用机制的研究,也具有十 分重要的意义。目前,人们通过人工检索和半自动检索的方式,从文献和蛋白质数据库（Protein Data Bank,PDB）中获得了许多蛋白质- 配体亲和力信息和生物相关配体信息,并构建了许多蛋白质-配体相互作用的信息数据库。对3 个蛋白质-配体亲和力数据库和6 个蛋白质 晶体结构-配体生物相关性数据库进行介绍,并对其主要应用进行简述,希望能为实现高效准确地筛选和设计药物提供一定的帮助。     

GEO-基因表达综合数据库的应用与数据挖掘

高通量微阵列杂交技术和测序技术的快速发展,产生了大量的基因数据,生物信息迅速膨胀成为数据的海洋。为适应这种高通量基因表达数据的不断增长和人们共享数据的需要,各种数据库应用而生,其中,NCBI（national center for biotechnology information）的基因表达综合数据库（gene expression omnibus,GEO）是世界上最大的储存高通量分子丰度数据的公共数据库,用户可以提交、储存和检索多种形式的数据并免费使用。迄今为止,GEO已收录了300000个样本的数据,涉及16亿个基因表达丰度数据,涵盖500多种生物体,广泛覆盖各种生物学内容。GEO数据库操作简单,数据全面,免费共享的优势为后期数据挖掘和信息推广提供了良好的平台。文章概述了GEO数据库的结构、数据的提交、检索和其在分子生物学领域中的应用前景。登陆GEO数据库的网址为：http：／／www．ncbi．nlm．nih．gov／geo。     

HSPVdb—the Human Short Peptide Variation Database for improved mass spectrometry-based detection of polymorphic HLA-ligands

T cell epitopes derived from polymorphic proteins or from proteins encoded by alternative reading frames (ARFs) play an important role in (tumor) immunology. Identification of these peptides is successfully performed with mass spectrometry. In a mass spectrometry-based approach, the recorded tandem mass spectra are matched against hypothetical spectra generated from known protein sequence databases. Commonly used protein databases contain a minimal level of redundancy, and thus, are not suitable data sources for searching polymorphic T cell epitopes, either in normal or ARFs. At the same time, however, these databases contain much non-polymorphic sequence information, thereby complicating the matching of recorded and theoretical spectra, and increasing the potential for finding false positives. Therefore, we created a database with peptides from ARFs and peptide variation arising from single nucleotide polymorphisms (SNPs). It is based on the human mRNA sequences from the well-annotated reference sequence (RefSeq) database and associated variation information derived from the Single Nucleotide Polymorphism Database (dbSNP). In this process, we removed all non-polymorphic information. Investigation of the frequency of SNPs in the dbSNP revealed that many SNPs are non-polymorphic “SNPs”. Therefore, we removed those from our dedicated database, and this resulted in a comprehensive high quality database, which we coined the Human Short Peptide Variation Database (HSPVdb). The value of our HSPVdb is shown by identification of the majority of published polymorphic SNP- and/or ARF-derived epitopes from a mass spectrometry-based proteomics workflow, and by a large variety of polymorphic peptides identified as potential T cell epitopes in the HLA-ligandome presented by the Epstein–Barr virus cells.     

Large Genomic Region Free of GWAS-Based Common Variants Contains Fertility-Related Genes

DNA variants, such as single nucleotide polymorphisms (SNPs) and copy number variants (CNVs), are unevenly distributed across the human genome. Currently, dbSNP contains more than 6 million human SNPs, and whole-genome genotyping arrays can assay more than 4 million of them simultaneously. In our study, we first questioned whether published genome-wide association studies (GWASs) assays cover all regions well in the genome. Using dbSNP build 135 data, we identified 50 genomic regions longer than 100 Kb that do not contain any common SNPs, i.e., those with minor allele frequency (MAF)≥1%. Secondly, because conserved regions are generally of functional importance, we tested genes in those large genomic regions without common SNPs. We found 97 genes and were enriched for reproduction function. In addition, we further filtered out regions with CNVs listed in the Database of Genomic Variants (DGV), segmental duplications from Human Genome Project and common variants identified by personal genome sequencing (UCSC). No region survived after those filtering. Our analysis suggests that, while there may not be many large genomic regions free of common variants, there are still some “holes” in the current human genomic map for common SNPs. Because GWAS only focused on common SNPs, interpretation of GWAS results should take this limitation into account. Particularly, two recent GWAS of fertility may be incomplete due to the map deficit. Additional SNP discovery efforts should pay close attention to these regions.     

Identification of RNA editing sites in the SNP database

The relationship between human inherited genomic variations and phenotypic differences has been the focus of much research effort in recent years. These studies benefit from millions of single-nucleotide polymorphism (SNP) records available in public databases, such as dbSNP. The importance of identifying false dbSNP records increases with the growing role played by SNPs in linkage analysis for disease traits. In particular, the emerging understanding of the abundance of DNA and RNA editing calls for a careful distinction between inherited SNPs and somatic DNA and RNA modifications. In order to demonstrate that some of the SNP database records are actually somatic modification, we focus on one type of these modifications, namely A-to-I RNA editing, and present evidence for hundreds of dbSNP records that are actually editing sites. We provide a list of 102 RNA editing sites previously annotated in dbSNP database as SNPs, and experimentally validate seven of these. Interestingly, we show how dbSNP can serve as a starting point to look for new editing sites. Our results, for this particular type of RNA editing, demonstrate the need for a careful analysis of SNP databases in light of the increasing recognition of the significance of somatic sequence modifications.     

Sequence variation in G-protein-coupled receptors: analysis of single nucleotide polymorphisms

We assessed the disease-causing potential of single nucleotide polymorphisms (SNPs) based on a simple set of sequence-based features. We focused on SNPs from the dbSNP database in G-protein-coupled receptors (GPCRs), a large class of important transmembrane (TM) proteins. Apart from the location of the SNP in the protein, we evaluated the predictive power of three major classes of features to differentiate between disease-causing mutations and neutral changes: (i) properties derived from amino-acid scales, such as volume and hydrophobicity; (ii) position-specific phylogenetic features reflecting evolutionary conservation, such as normalized site entropy, residue frequency and SIFT score; and (iii) substitution-matrix scores, such as those derived from the BLOSUM62, GRANTHAM and PHAT matrices. We validated our approach using a control dataset consisting of known disease-causing mutations and neutral variations. Logistic regression analyses indicated that position-specific phylogenetic features that describe the conservation of an amino acid at a specific site are the best discriminators of disease mutations versus neutral variations, and integration of all our features improves discrimination power. Overall, we identify 115 SNPs in GPCRs from dbSNP that are likely to be associated with disease and thus are good candidates for genotyping in association studies.     

ALFRED: an allele frequency database for diverse populations and DNA polymorphisms

We have developed a publicly accessible database (ALFRED, the ALlele FREquency Database) that catalogues allele frequency data for a wide range of population samples and DNA polymorphisms. This database is web-accessible through our laboratory (Kidd Lab) Web site: http://info.med.yale.edu/genetics/kkidd. ALFRED currently contains data on 60 populations and 156 genetic systems including single nucleotide polymorphisms (SNPs), short tandem repeat polymorphisms (STRPs), variable number of tandem repeats (VNTRs) and insertion-deletion polymorphisms. While data are not available for all population-DNA polymorphism combinations, over 2000 allele frequency tables have been entered. Our database is designed (i) to address our specific research requirements as well as broader scientific objectives; (ii) to allow researchers and interested educators to easily navigate and retrieve data of interest to them; and (iii) to integrate links to other related public databases such as dbSNP, GenBank and PubMed.     

Discrepancies in dbSNP confirmation rates and allele frequency distributions from varying genotyping error rates and patterns

SUMMARY: Three recent publications have examined the quality and completeness of public database single nucleotide polymorphism (dbSNP) and have come to dramatically different conclusions regarding dbSNPs false positive rate and the proportion of dbSNPs that are expected to be common. These studies employed different genotyping technologies and different protocols in determining minimum acceptable genotyping quality thresholds. Because heterozygous sites typically have lower quality scores than homozygous sites, a higher minimum quality threshold reduces the number of false positive SNPs, but yields fewer heterozygotes and leads to fewer confirmed SNPs. To account for the different confirmation rates and distributions of minor allele frequencies, we propose that the three confirmation studies have different false positive and false negative rates. We developed a mathematical model to predict SNP confirmation rates and the apparent distribution of minor allele frequencies under user-specified false positive and false negative rates. We applied this model to the three published studies and to our own resequencing effort. We conclude that the dbSNP false positive rate is approximately 15-17% and that the reported confirmation studies have vastly different genotyping error rates and patterns.     

Detection and validation of non-synonymous coding SNPs from orthogonal analysis of shotgun proteomics data

Orthogonal analysis of amino acid substitutions as a result of SNPs in existing proteomic datasets provides a critical foundation for the emerging field of population-based proteomics. Large-scale proteomics datasets, derived from shotgun tandem MS analysis of complex cellular protein mixtures, contain many unassigned spectra that may correspond to alternate alleles coded by SNPs. The purpose of this work was to identify tandem MS spectra in LC-MS/MS shotgun proteomics datasets that may represent coding nonsynonymous SNPs (nsSNP). To this end, we generated a tryptic peptide database created from allelic information found in NCBI's dbSNP. We searched this database with tandem MS spectra of tryptic peptides from DU4475 breast tumor cells that had been fractioned by pI in the first-dimension and reverse-phase LC in the second dimension. In all we identified 629 nsSNPs, of which 36 were of alternate SNP alleles not found in the reference NCBI or IPI protein databases. Searches for SNP-peptides carry a high risk of false positives due both to mass shifts caused by modifications and because of multiple representations of the same peptide within the genome. In this work, false positives were filtered using a novel peptide pI prediction algorithm and characterized using a decoy database developed by random substitution of similarly sized reference peptides. Secondary validation by sequencing of corresponding genomic DNA confirmed the presence of the predicted SNP in 8 of 10 SNP-peptides. This work highlights that the usefulness of interpreting unassigned spectra as polymorphisms is highly reliant on the ability to detect and filter false positives.     

Combined sequence and sequence-structure-based methods for analyzing RAAS gene SNPs: a computational approach

Abstract

The renin–angiotensin–aldosterone system (RAAS) plays a key role in the regulation of blood pressure (BP). Mutations on the genes that encode components of the RAAS have played a significant role in genetic susceptibility to hypertension and have been intensively scrutinized. The identification of such probably causal mutations not only provides insight into the RAAS but may also serve as antihypertensive therapeutic targets and diagnostic markers. The methods for analyzing the SNPs from the huge dataset of SNPs, containing both functional and neutral SNPs is challenging by the experimental approach on every SNPs to determine their biological significance. To explore the functional significance of genetic mutation (SNPs), we adopted combined sequence and sequence-structure-based SNP analysis algorithm. Out of 3864 SNPs reported in dbSNP, we found 108 missense SNPs in the coding region and remaining in the non-coding region. In this study, we are reporting only those SNPs in coding region to be deleterious when three or more tools are predicted to be deleterious and which have high RMSD from the native structure. Based on these analyses, we have identified two SNPs of REN gene, eight SNPs of AGT gene, three SNPs of ACE gene, two SNPs of AT1R gene, three SNPs of CYP11B2 gene and three SNPs of CMA1 gene in the coding region were found to be deleterious. Further this type of study will be helpful in reducing the cost and time for identification of potential SNP and also helpful in selecting potential SNP for experimental study out of SNP pool.     

Structural location of disease-associated single-nucleotide polymorphisms

Non-synonymous single-nucleotide polymorphism (nsSNP) of genes introduces amino acid changes to proteins, and plays an important role in providing genetic functional diversity. To understand the structural characteristics of disease-associated SNPs, we have mapped a set of nsSNPs derived from the online mendelian inheritance in man (OMIM) database to the structural surfaces of encoded proteins. These nsSNPs are disease-associated or have distinctive phenotypes. As a control dataset, we mapped a set of nsSNPs derived from SNP database dbSNP to the structural surfaces of those encoded proteins. Using the alpha shape method from computational geometry, we examine the geometric locations of the structural sites of these nsSNPs. We classify each nsSNP site into one of three categories of geometric locations: those in a pocket or a void (type P); those on a convex region or a shallow depressed region (type S); and those that are buried completely in the interior (type I). We find that the majority (88%) of disease-associated nsSNPs are located in voids or pockets, and they are infrequently observed in the interior of proteins (3.2% in the data set). We find that nsSNPs mapped from dbSNP are less likely to be located in pockets or voids (68%). We further introduce a novel application of hidden Markov models (HMM) for analyzing sequence homology of SNPs on various geometric sites. For SNPs on surface pocket or void, we find that there is no strong tendency for them to occur on conserved residues. For SNPs buried in the interior, we find that disease-associated mutations are more likely to be conserved. The approach of classifying nsSNPs with alpha shape and HMM developed in this study can be integrated with additional methods to improve the accuracy of predictions of whether a given nsSNP is likely to be disease-associated.